Safety and efficacy of L-carnitine supplementation in patients with hematopoietic stem cell transplantatio
Not Applicable
- Conditions
- Hematological malignancy, Bone marrow failure syndrome
- Registration Number
- JPRN-UMIN000012424
- Lead Sponsor
- Sapporo Medical University School of Medicine, Department of Medical Oncology and Hematology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Exclusion criteria included intake of carnitine in the last two months, carnitine allergy, severe complications, pregnancy, severe mental illness.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method